FDA Endorses Teplizumab for Delaying Type 1 Diabetes

FDA Endorses Teplizumab for Delaying Type 1 Diabetes

Bydiabetesknow

Previously Published on Medscape.com – A US Food and Drug Administration (FDA) advisory panel has voted narrowly to recommend approval of the monoclonal antibody teplizumab (Tzield,Provention Bio) for the delay of type 1 diabetes in at-risk individuals. (FDA Endorses Teplizumab) The 10-7 vote of the FDA’s Endocrinologic and Metabolic Drugs advisory committee on May 27 reflected a…

Transforming alpha cells into beta cells treats diabetes?

Transforming alpha cells into beta cells treats diabetes?

Bydiabetesknow

Previously Published on MedicalNewsToday – Diabetes keeps the body from being able to regulate levels of glucose in the blood. In the long term, this can lead to a wide range of life-changing complications, including vision loss, kidney damage, stroke, and heart disease. Therefore, transforming alpha cells into beta cells makes sense. In the United…